期刊文献+

抗核抗体阳性肝硬化患者的临床特点 被引量:2

Clinical distinguishing features in cirrhosis patients with positive antinuclear antibody.
下载PDF
导出
摘要 为了探讨抗核抗体 (ANA)阳性肝硬化患者的临床特点及环磷酰胺的治疗效果 ,检测 82例肝硬化患者血清ANA ,比较ANA阴性和阳性肝硬化患者的临床特点 ,观察环磷酰胺治疗ANA阳性肝硬化患者的疗效。结果与ANA阴性肝硬化患者比较 ,ANA阳性肝硬化患者女性多见 ,发病年龄较大 ,乙型肝炎病毒感染率低 ,Child -Pugh分级C级比例高 ;腹水、下肢浮肿症状较重 ;血清白蛋白水平低、球蛋白水平高 (P <0 0 5 )。ANA阳性肝硬化患者经环磷酰胺治疗后症状均好转 ,其中与对照组比较 ,腹水、下肢浮肿症状改善明显 (P <0 0 5 ) ;血清总蛋白、白蛋白水平增加 ,球蛋白水平下降 (P <0 0 5 ) ;部分患者ANA转阴 (P <0 0 5 )。说明ANA阳性肝硬化患者有其自身的临床特点 ,环磷酰胺治疗有效。 To investigate clinical features in cirrhosis patients with serum positive antinuclear antibody(ANA) and the treating effect of cyclophosphamide on these patients. The serum ANA level was tested in patients with cirrhosis. Clinical features of cirrhosis patients with serum positive ANA were compared with negative, and the treating effect of cyclophosphamide on cirrhosis patients with serum positive ANA was investigated. Compared with the cases with negative ANA, the cases with serum positive ANA and more female, lower infected rate of hepatitis B virus and higher proportion of Child-Pugh hierarchical C grade (P<0.05), in which the symptoms of ascites and legs edema were worse significantly (P<0.05)and whose age were older (P<0.05);The serum albumin and total globulin levels in cirrhosis patients with positive ANA dropped significantly. After having been treated with cyclophosphamide in cirrhosis patients with serum positive ANA, ascites and legs edema symptoms were improved significantly (P<0.05),serum albumin level rose and globulin level dropped significantly (P<0.05). The cirrhosis patients with positive ANA have theirs clinical distinguishing features and cyclophosphamide is an effective therapeutic medication.
出处 《临床肝胆病杂志》 CAS 北大核心 2004年第3期136-137,共2页 Journal of Clinical Hepatology
关键词 抗核抗体阳性 肝硬化 临床特点 环磷酰胺 治疗 Cirrhosis Antinuclear antibody Cyclophosphamide
  • 相关文献

参考文献6

  • 1范列英,仲人前,赵文静,夏晴.慢性肝病和原发性肝癌患者血清抗核抗体检测及其临床意义[J].上海免疫学杂志,2000,20(2):120-121. 被引量:20
  • 2Lau CF, Hui PK, Chan WM, et al. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide,prednisolone and lamivudine following emergency surgery[J]. Eur J Gastroenterol Hepatol, 2002, 14(5) :563 - 566. 被引量:1
  • 3Kast RE. Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function[ J ]. Neplasia, 2003,5(1): 3 - 8. 被引量:1
  • 4Kim S, Liva S M, Dalal M A. Estriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis[J]. Neurology, 1999,52(6): 1230- 8. 被引量:1
  • 5Medina J, Garcia- Buey L, Moreno- Otero R. Immunopathogenetic and therapeutic aspects of autoimmune hepatitis[J] .Aliment Pharmacol Ther,2003,17(1): 1 - 16. 被引量:1
  • 6Filippini D, Colombo F, Jann S, et al. Central nervous system involvement in patients with HCV - related cryoglobulinemia: literature review and a case report[J]. Reumatismo, 2002, 54(2):150- 155. 被引量:1

二级参考文献4

  • 1[1]Covini G,von-Muhlen CA,Pacchetti S,et al.Diversity of antinuclear antibody responses in hepatocellular carcinoma.J Hepatol,1997;26:1255 被引量:1
  • 2[2]Strassburg CP,Alex B,Zindy P,F, et al.Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and nonhepatic antoimmune diseases.J Hepatol,1996;25:859 被引量:1
  • 3[3]Numata T,Kato J,Kohgo Y,et al.Autoantibody against a 78 Kda membrane protein of HEpG2 cell in the sera of patients with alcoholic liver diseases.J Gastroenterol,1995;30:751 被引量:1
  • 4[4]Haruhiko I,Robert LO,Kendo KS,et al.Nucleolar antigens and autoantibodies hepatocellular carcinoma and other malignancies.Ame J Pathol,1992;140:859 被引量:1

共引文献19

同被引文献18

  • 1关伟,高艳,周云芳.慢性乙肝及肝硬化患者血清自身抗体结果分析[J].哈尔滨医药,2005,25(4):10-11. 被引量:1
  • 2Kim S, Liva S M, Dalai M A. Estriol ameliorates autoimmune demyelihating disease: implications for multiple sclerosis[J]. Neurology, 1999, 52(6) : 1230 - 1238. 被引量:1
  • 3Kast RE. Ribavirin in cancer immunotherapies: controlling nitric oxideaugments cytotoxic lymphocyte function[ J ]. Neplasia, 2003,5 ( 1 ) : 3 - 8. 被引量:1
  • 4Medina J, Garcia - BueyL, Moreno - Otero R. Immunopathogenetic and therapeutic aspects of autoimmtme hepatitis[J ]. Aliment Pharmacol Ther,2003,17(1) : 1 - 16. 被引量:1
  • 5Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F,Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D,Bianchi FB.Serum autoantibodies in chronic hepatitis C:comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26:561- 566 被引量:1
  • 6Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C withautoimmune features. Hepatology 1997; 26:459- 466 被引量:1
  • 7Wada M, Kang KB, Kinugasa A, Shintani S, Sawada K,Nishigami T, Shimoyama T. Does the presence of serum autoant-ibodies influence the responsiveness to interferon-alpha 2a treatment .in.chronic hepatitis C. Intern Med 1997; 36: 248- 254 被引量:1
  • 8Ferri C, La Civita L, Monti M, Giannini C, Cecchetti R,Caracciolo F,Longombardo G,Lombardini F, Zignego AL.Chronic hepatitis C and B-cell non-Hodgkins lymphoma. QJ M 1996; 89:117-122 被引量:1
  • 9De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A,Cornacchiulo V, Sanffni G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M. Hepatitis C virus within a malignant lymphoma lesion in the course of type Ⅱ mixed cryoglobulinemia. Blood 1995; 86:1887-1892 被引量:1
  • 10Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-619 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部